Introduction {#Sec1}
============

Spinal metastases are a common manifestation of malignant diseases and have been reported in autopsy-studies in 30--70% of cancer patients since the 1950s \[[@CR1]--[@CR3]\]. Due to improvements in diagnostic and treatment of cancer, along with an aging population, the number of patients surviving years beyond their cancer diagnosis has increased and consequently also the incidence of spinal metastases \[[@CR4]--[@CR6]\]. Breast, prostate, lung and kidney tumors most commonly disseminate into the spine \[[@CR7]\]. Metastases are thereby most frequently located within the thoracic spine, followed by the lumbar and cervical spine \[[@CR7], [@CR8]\]. In more than 30% of cases, spinal metastases are discontinuously located on multiple vertebral-levels \[[@CR9], [@CR10]\].

Despite local back-pain being the initial symptom in most patients, spinal metastases are frequently diagnosed not before neurological deficits occur \[[@CR9], [@CR11], [@CR12]\]. These may include sensory and motor disturbances as well as autonomic dysfunction \[[@CR11], [@CR13]\]. Progression of the epidural masses leads to metastatic spinal cord compression (MSCC) and might finally result in complete and irreversible paraplegia, unless timely treatment is initiated \[[@CR14]\]. This most serious and devastating sequel of spinal metastases is termed malignant epidural spinal cord compression (MESCC) and occurs in 3--5% of all cancer patients \[[@CR15], [@CR16]\]. Although MESCC does not directly alter life expectancy, its' severe clinical course results in rapid deterioration of neurological function culminating in a paraplegic status. Finally, this loss of ambulation leads to a significant reduction of the patients' quality of life \[[@CR7], [@CR11]\]. It is understood that MESCC has to be treated as an oncological emergency, requiring rapid decision-making if neurological function should be preserved \[[@CR13], [@CR17]\]. In this context, early therapeutic intervention as well as a good neurological status prior to treatment-initiation are repeatedly accounted for a better functional outcome \[[@CR18]--[@CR20]\].

Treatment options for MSCC include the administration of corticosteroids, chemotherapy, different forms of radiotherapy as well as different surgical approaches \[[@CR6], [@CR17], [@CR21]\]. Surgery, however, remains the only treatment option leading to immediate relief of neural compression. In addition, it can ascertain histopathological diagnosis \[[@CR17]\]. Indications widely accepted for decompression surgery include rapid neurologic deterioration, pain unresponsive to conservative treatment or radio-resistant tumors \[[@CR22]\]. Decompressive laminectomy has been the surgical treatment of choice for MSCC patients, lowering mortality and morbidity rates \[[@CR15]\], but several reports on inadequate decompression and poor neurological outcome have initiated a critical discussion about the use of this technique \[[@CR9], [@CR23]--[@CR28]\]. Apart from that, individualized surgical approaches were further developed \[[@CR29]--[@CR31]\] and despite the fact that the presence of spinal metastases makes most subsequent therapies palliative, radical surgical approaches encompassing gross total tumor resection with replacement of vertebral bodies combined with anterior or posterior stabilization were established in order to offer further treatment alternatives aiming for oncological cure \[[@CR32]--[@CR35]\]. Nevertheless, indication for surgery has to take into account that patients with spinal metastases often suffer from multiple disseminated metastases and severe comorbidities, and thus mostly are in a reduced general condition with limited life expectancy \[[@CR19], [@CR36], [@CR37]\]. Considering these issues, radical and curative tumor resection often appears challenging when surgery should not impair the patients' remaining quality of life \[[@CR38]\].

Although several studies have evaluated prognostic factors that may affect survival \[[@CR39]--[@CR41]\] or the psychological status of MSCC patients, only limited information is available on their quality of life before and after treatment \[[@CR42]--[@CR46]\]. Especially in cancer patients, quality of life is strongly dependent on the ambulatory status which in turn is mostly affected by MSCC. Independent from comorbidities and tumor expansion, decompressive laminectomy remains a straightforward surgical technique that might have the potential to improve neurological function in selected MSCC patients, potentially preventing loss of ambulation and improving quality of life.

The aim of the current study therefore was to present data on the early postoperative ambulatory status of neurologically impaired MSCC patients without spinal instability who were surgically treated by decompressive laminectomy and to identify factors that may reinstitute their ability to walk.

Methods {#Sec2}
=======

Patient selection {#Sec3}
-----------------

A single center retrospective analysis of all consecutive patients with metastatic spinal cord compression who underwent decompressive laminectomy with the primary goal of maximum posterior decompression at our institution between 2004 and 2014 was performed. Adult patients (≥ 18 years) with neurological impairment at admission, a tissue-proven diagnosis of solid primary tumor and evidence of MSCC by an epidural mass on imaging were further analyzed. Patients with pain as their only symptom at admission as well as radiosensitive tumors originating from the bone marrow, the cartilages or the lymphatic system and tumors originating from the central nervous system were excluded. Furthermore, cases in which spinal instability according to the Spinal Instability Neoplastic Score (SINS \> 12) was present and in which additional stabilization of the vertebral column was required were excluded as well (Fig. [1](#Fig1){ref-type="fig"}). The local standing committee of ethnical practice approved the protocol of this study.Fig. 1Flow-diagram of patient selection (*MSCC* metastatic spinal cord compression, *SINS* spinal instability neoplastic score)

Clinical evaluation and outcome assessment {#Sec4}
------------------------------------------

Information was collected from the patients' hospital records including demographics, clinical presentation and duration of symptoms, preoperative imaging findings, surgical details, perioperative management and surgical or non-surgical complications as well as the pre- and postoperative neurological status. Perioperative mortality was defined as death during the in-hospital stay.

For morphological evaluation of MSCC, the 6-point Epidural Spinal Cord Compression (ESCC) scale \[[@CR47]\] was determined as a consensus decision of three independent raters on preoperative imaging \[[@CR47]\]. To determine spinal stability, the SINS score \[[@CR48]\], which assesses tumor-related instability by adding together scores for spinal location, pain, lesion bone quality, radiographic alignment, vertebral body collapse and posterolateral involvement of the spinal elements was calculated for every patient \[[@CR49]\]. Furthermore, the modified Tokuhashi score \[[@CR39]\] was determined for each patient. This score uses six parameters (general condition, extraspinal bone metastases, metastases in the vertebral body, metastases to major organs, primary tumor site, spinal cord palsy) ranging from 0 to 5 points with a total score of 15 points and can be used for pretreatment evaluation of metastatic spinal tumor prognosis \[[@CR39]\]. Karnofsky performance status (KPS) scale \[[@CR50]\] and Frankel Grade (FG) \[[@CR51]\] at admission and at the day of discharge, obtained by the treating physicians were collected to assess the patients' functional outcome. The ambulatory status at discharge was thereby used as the primary outcome parameter and ambulation was defined as a Frankel Grade of D or E.

Statistical analysis {#Sec5}
--------------------

For statistical comparison, subgroups of patients with and without an ambulatory status at admission as well as at discharge were formed. The p-values for categorical variables (gender, primary (first) symptom, ambulation, imaging, location of metastases, complications, revisions, etc.) were calculated with Fisher's exact test. For comparison of continuous variables (age, inpatient stay, number of metastases, time from onset to surgery, ESCC, Tokuhashi score, KPS, FG, strength level, duration of paresis, time point of surgery, etc.), a two-sided Student's t test was used. Additionally, associations between the described variables and the retrieval of ambulation at the time of discharge were assessed in univariate analysis. No adjustment for multiple testing was performed as this was an exploratory analysis. All statistical analyses were conducted using GraphPad Prism 7.0b. A p-value \< 0.05 was considered statistically significant.

Results {#Sec6}
=======

Patient demographics {#Sec7}
--------------------

A total of 101 eligible patients (74 male, 27 female) with a mean age of 66.1 ± 11.5 years (mean ± SD) was identified. Spinal metastases originated from the prostate in 40 (40%), the lung in 23 (23%), and the breast in 11 (11%) of cases. Other tumors (including kidney, melanoma, larynx, and GI.) accounted for 19 (19%) of the metastases. Most patients (74%) were in a progressive stage of the underlying malignant disease with at least one additional, extraspinal metastasis. In eight patients (8%), the existence of a malignant disease had still been unknown at the time of presentation. (Table [1](#Tab1){ref-type="table"}).Table 1Patient demographics and imaging findingsCharacteristicsValuesNumber of patients101Sex (%) Male74 (73%) Female27 (27%)Age (median, IQR / mean ± mean)66, 57--75 years / 66.1 ± 11.5 yearsOrigin of metastases (%) Prostate40 (40%) Lung23 (22%) Breast11 (11%) Others19 (19%) Unknown8 (8%)Progressive disease (%)^a^75 (74%)Number of metastases (%)Solitary31 (31%) 2--540 (40%) \> 530 (29%)Location of metastases (%) Cervical7 (7%) Thoracic79 (78%) Lumbar15 (15%) Sacral0 (0%)Rad. sign of myelopathy (%)38 (38%)ESCC scale (%) 1a1 (1%) 1b0 (0%) 1c2 (2%) 226 (26%) 372 (71%)SINS score (%) SINS 0--682 (81%) SINS 7--1219 (19%) SINS 13--180 (0%)*IQR* inter quartile range, *SD* standard deviation, *ESCC* epidural spinal cord compression, *SINS* spinal instability neoplastic score^a^At least one additional extraspinal metastasis

Imaging {#Sec8}
-------

MR images of the spine were performed in 93 patients (92%). Since contraindications for MR imaging, the remaining 8% of patients received CT scans only. Thirty-one patients (31%) had a single metastasis in only one vertebral body, whereas 70 patients (69%) presented with multiple lesions, sometimes located in distant parts of the spinal column. Most metastases involved the thoracic spine (n = 79, 78%), whereby the spinal level Th 4--7 were affected in a majority of cases (43%), followed by the lumbar (n = 15, 15%) and the cervical spine (n = 7, 7%). The cervico-thoracic or thoraco-lumbar junctions were affected in 3 (3%) and 1 (1%) case, respectively. Morphological evaluation of MSCC revealed an ESCC grade of 1a in 1 (1%), of 1c in 2 (2%), of 2 in 26 (26%) and of 3 in 72 (71%) patients. No patient had an ESCC grade of 0, or 1b. Spinal stability measured by the SINS score showed complete stable conditions in 81% of cases (n = 82) and an average SINS score of 5 ± 2.26 (mean ± SD). Intermediate stability was present in 19 patients (19%) and no patient had an instable spine. (Table [1](#Tab1){ref-type="table"}).

Clinical presentation {#Sec9}
---------------------

The most relevant symptoms determined by the patients prior to admission and mostly the reason for patient referral to our institution were motor palsy in 63% of cases (n = 64), followed by pain in 20% (n = 20) and sensory deficits in only 12% (n = 12) of cases. These symptoms had been present since a median of 5 days prior to hospitalization (IQR 2--14 days).

Neurological examination at admission revealed paresis in 101 patients (100%) with muscle strength of grade 3 or less according to the British Medical Research Council (BMRC) grading system \[[@CR52]\] and thus, the inability to move the corresponding extremities against gravity. Sensory deficits were present in 83 patients (82%) and abnormal urinary sphincter function was present in 60 patients (60%) whereas bowel dysfunction only occurred in 25 patients (25%). Nearly half of the patients suffered from back pain (n = 49, 49%) while radiating pain was rare (n = 13, 13%). Most importantly, all patients (100%) showed impaired ambulation (FG A--D) and 81 patients (80%) had even completely lost ambulation at admission (FG A--C). Nearly all patients (96%) thus were unable to work or carry out normal activities of daily living measured by the Karnofsky Performance Index (KPI score \< 80%). (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).Table 2Comparison of preoperative non-ambulatory (n = 81) and ambulatory (n = 20) patientsCharacteristicAllNon-ambulatory preoperativelyAmbulatory preoperativelyp-valueNumber of patients1018120First symptom (%) Paresis64 (63%)56 (69%)8 (40%)0.0205^2^ Pain20 (20%)12 (15%)8 (40%)0.0240^2^ Sensory deficit12 (12%)9 (11%)3 (15%)0.7006^2^ Bowl/bladder dysfunction5 (5%)4 (5%)1 (5%)\> 0.9999^2^Duration of first symptom (median, IQR / mean ± SD)5, 2--14 days / 17.3 ± 42.5 days5, 2--14 days / 10.9 ± 16.1 days10, 2--35 days / 42.85 ± 86.8 days0.0022^1^KPI (median, IQR / mean ± SD)40, 30--50% / 42.8 ± 13.4%40, 30--40% / 38.3 ± 8.5%60, 50--70% / 61 ± 14.5%\< 0.0001^1^FG on admission (%) Grade A17 (17%)17 (21%)0 (0%)0.0209^2^ Grade B11 (11%)11 (14%)0 (0%)0.1151^2^ Grade C53 (52%)53 (65%)0 (0%)\< 0.0001^2^ Grade D20 (20%)0 (0%)20 (100%)\< 0.0001^2^ Grade E0 (0%)0 (0%)0 (0%)Symptoms on admission (%) Paresis101 (100%)81 (100%)20 (100%)\> 0.9999^2^ Back pain49 (49%)36 (44%)13 (65%)0.1346^2^ Radiating pain13 (13%)6 (7%)7 (35%)0.0035^2^ Sensory deficit83 (82%)68 (84%)15 (75%)0.3434^2^ Bladder dysfunction60 (59%)54 (67%)6 (30%)0.0045^2^ Bowl dysfunction25 (25%)25 (31%)0 (0%)0.0027^2^Duration of paresis (median, IQR / mean ± SD)4.5, 2--10 days / 11.6 ± 26.3 days4, 1.5--7 days / 7.2 ± 11.5 days10, 3--21 days / 30.1 ± 52.5 days0.0005^1^Degree of paresis (%)\< 0.0001^2^ \> Grade 3/5 BMRC24 (24%)7 (9%)17 (85%) \< Grade 4/5 BMRC77 (76%)74 (91%)3 (15%)Location of metastases (%) Cervical6 (6%)4 (5%)2 (10%)0.3396^2^ Thoracic81 (80%)66 (82%)15 (75%)0.5374^2^ Lumbar13 (13%)10 (12%)3 (15%)0.7177^2^ Sacral0 (0%)0 (0%)0 (0%)Rad. sign of myelopathy (%)38 (38%)33 (41%)5 (25%)0.3024^2^ESCC scale (%) 1a1 (1%)0 (0%)1 (5%)0.1980^2^ 1c2 (2%)0 (0%)2 (10%)0.0376^2^ 226 (26%)19 (23%)7 (35%)0.3912^2^ 372 (71%)62 (77%)10 (50%)0.0272^2^Tokuhashi score (%) 0--863 (62%)55 (68%)8 (40%)0.0372^2^ 9--1135 (35%)26 (32%)9 (45%)0.3025^2^ 12--153 (3%)0 (0%)3 (15%)0.0068^2^ASA score (%) \< ASA 326 (26%)14 (18%)8 (40%)0.0681^2^ \> ASA 275 (74%)63 (82%)12 (60%)Time to surgery after adm (median, IQR / mean ± SD)13, 8--25 h / 24 ± 36 h12, 8--23.5 h / 23 ± 38 h22, 10--48 h / 31 ± 26 h0.4067^1^Levels decompressed (median, IQR / mean ± SD)2, 1--2 / 1.9 ± 0.92, 1--2 / 1.8 ± 0.82, 1--2.7 / 1.9 ± 0.90.8482^1^Duration of surgery (median, IQR / mean ± SD)130, 105--160 min /138.4 ± 49.5 min130, 105--150 min / 135 ± 46 min142, 97.7--200 min / 151 ± 60 min0.4074^1^Complications (%)6 (6%)6 (7%)0 (0%)0.3508^2^Revision surgery (%)4 (4%)4 (5%)0 (0%)0.5821^2^Hospital length of stay8, 6--12 days8, 5.5--12 days9, 7--13 days0.1897^1^(median, IQR/mean ± mean)9 ± 4.7 days9 ± 5 days10 ± 5 daysFG on discharge (%) Grade A9 (9%)9 (11%)0 (0%)0.1978^2^ Grade B3 (3%)3 (4%)0 (0%)\> 0.9999^2^ Grade C27 (27%)27 (34%)0 (0%)0.0013^2^ Grade D49 (49%)38 (47%)11 (55%)0.2823^2^ Grade E12 (12%)3 (4%)9 (45%)0.011^2^*SD* standard deviation, *IQR* inter quartile range, *FG* Frankel grade, *KPI* Karnofsky performance index, *ESCC* epidural spinal cord compression, *SINS* Spinal instability neoplastic score, *ASA* American Society of Anesthesiologists^1^Student's t-test^2^Fishers exact testTable 3Comparison of postoperative non-ambulatory (n = 40) and ambulatory (n = 61) patientsCharacteristicAllNon-ambulatory postoperativelyAmbulatory postoperativelyp-valueNumber of patients1014061Sex (%)\< 0.0001^2^ Male74 (73%)27 (67.5%)47 (77%) Female27 (27%)13 (32.5%)14 (23%)First symptom (%) Paresis64 (63%)30 (75%)34 (67%)0.4895^2^ Pain20 (20%)5 (13%)15 (24%)0.2016^2^ Sensory deficit12 (12%)4 (10%)8 (13%)0.7592^2^ Bowl/bladder dysfunction5 (5%)1 (2.5%)4 (7%)0.7092^2^Duration of first symptom (median, IQR / mean ± SD)5, 2--14 days / 17.3 ± 42.5 days7, 2--14 days / 12.85 ± 18.5 days5, 2.5--14 days / 20.1 ± 52.6 days0.3229^1^KPI on admission \< 50%73 (72%)38 (95%)35 (57%)\< 0.0001^2^ \> 40%28 (28%)2 (5%)26 (43%)FG on admission (%) Grade \< D81 (80%)40 (100%)41 (67%)\< 0.0001^2^ Grade \> C20 (20%)0 (0%)20 (33%)Symptoms on admission (%) Paresis101 (100%)81 (100%)20 (100%)\> 0.9999^2^ Back pain49 (49%)17 (43%)32 (52%)0.4164^2^ Radiating pain13 (13%)2 (5%)11 (18%)0.0711^2^ Sensory deficit83 (82%)32 (80%)51 (84%)0.7911^2^ Bladder dysfunction60 (59%)29 (73%)31 (51%)0.0387^2^ Bowl dysfunction25 (25%)19 (48%)6 (10%)\< 0.0001^2^Duration of paresis (median, IQR / mean ± SD)4.5, 2--10 days / 11.6 ± 26.3 days4, 1--14 days / 9.3 ± 15.3 days5, 2--10 days / 13.1 ± 31.6 days0.4268^1^Degree of paresis (%) \> Grade 3/5 BMRC24 (24%)1 (3%)23 (62%)\< 0.0001^2^ \< Grade 4/5 BMRC77 (76%)39 (97%)38 (38%)Ambulatory status on admission Able to walk20 (20%)0 (0%)20 (33%)\< 0.0001^2^ Unable to walk81 (80%)40 (100%)41 (67%)Duration of inability to walk (median, IQR / mean ± SD)48, 24--96 h / 71 ± 76.5 h24, 24--72 h / 70 ± 89.7 h48, 24--96 h / 72 ± 62.9 h0.9107^2^Tokuhashi score (%) 0--863 (62%)30 (75%)33 (54%)0.0382^2^ 9--1135 (35%)10 (25%)25 (41%)0.1347^2^ 12--153 (3%)0 (0%)3 (5%)0.2752^2^ASA score (%) \< ASA 326 (26%)5 (14%)17 (28%)0.1337^2^ \> ASA 275 (74%)32 (86%)43 (72%)Time to surgery (%) \< 24 h after admission72 (72%)30 (75%)42 (70%)0.6537^2^ \> 24 h after admission28 (28%)10 (25%)18 (30%)Duration of surgery (median, IQR / mean ± mean)130, 105--160 min / 138.4 ± 49.5 min130, 105--153 min / 139 ± 50 min131, 100--161 min / 138 ± 49.7 min0.9277^1^Complications (%)6 (6%)3 (7.5%)3 (5%)0.2589^2^Revision surgery (%)4 (4%)1 (3%)3 (5%)\> 0.9999^2^Hospital length of stay (median, IQR / mean ± SD)8, 6--12 days / 9 ± 4.7 days7.5, 4--12 days / 8.5 ± 4.8 days8, 6--12 days / 9.4 ± 4.7 days0.3676^1^Improvement on discharge (%) KPI75 (74%)24 (60%)51 (84%)0.0107^2^ Frankel Grade61 (61%)11 (28%)50 (82%)\< 0.0001^2^ Ambulation41 (41%)0 (0%)41 (67%)\< 0.0001^2^ Paresis69 (68%)23 (58%)46 (75%)0.0802^2^ Back pain23 (23%)7 (50%)16 (50%)\> 0.9999^2^ Radiating pain7 (7%)0 (0%)7 (64%)0.1923^2^ Sensory deficit15 (15%)3 (10%)12 (25%)0.1454^2^ Bladder dysfunction19 (19%)4 (14%)15 (54%)0.0041^2^ Bowl dysfunction5 (5%)2 (11%)3 (60%)0.0482^2^*SD* standard deviation, *IQR* inter quartile range, *FG* Frankel Grade, *KPI* Karnofsky Performance Index, *BMRC* British Medical Research Council, *ESCC* Epidural Spinal Cord Compression, *SINS* Spinal Instability Neoplastic Score, *ASA* American Society of Anesthesiologists^1^Students t-test^2^Fishers exact test

Surgical management and complications {#Sec10}
-------------------------------------

Following informed consent, surgical treatment was performed as an emergency procedure within 24 h after admission in 72 cases (71%). The overall median time to surgery was 13 h (IQR 8--24.75 h) after admission, and 65 h (IQR 32.5--100 h) after loss of ambulation. Due to the vast progression of tumor disease, patients showed severe systemic co-morbidities with an ASA score (American Society of Anesthesiologists Physical Status Classification System score) of III in 62% (n = 60) and IV in 15% (n = 15) of cases. Intraoperatively, a median of 2 spinal segments (IQR 1--2) were posteriorly decompressed by laminectomy.

Surgery-related complications occurred in four patients (4%), consisting of three cases of secondary hemorrhage which all required revision surgery and one case of wound infection which required revision surgery as well. Additionally, general complications occurred in two patients (2%), both displaying symptoms of cardiorespiratory insufficiency. One of those two patients developed a myocardial infarction and died during the in-hospital stay. Overall complication rate was therefore 6%, revision rate 4% and mortality rate 1%. Patients could be discharged from the surgical ward after 9 ± 4.7 days (mean ± SD) (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).

Postoperative outcome and impact on ambulation {#Sec11}
----------------------------------------------

At discharge, 83 patients (84%) reported that their symptoms had overall improved. Especially palsies showed good recovery (improvement in 73% of cases) followed by alleviation of pain (radiating pain in 54% and back pain in 47% of cases) whereas sensory deficits as well as bladder or bowl dysfunction were often persistent (improvement in 18%, 24%, and 20% of cases, respectively).

Pre-operatively impaired neurological function (Frankel Grade A--D) had improved by ≥ 1 grade in the Frankel Grade in 61% of patients at discharge (Fig. [2](#Fig2){ref-type="fig"}a). To emphasize, 25% of all severely impaired patients (Frankel Grade A and B prior to surgery) and 51% of all non-ambulatory patients (Frankel Grade A--C) had regained ambulation after surgery (Fig. [2](#Fig2){ref-type="fig"}b). Overall, 61 patients (61%) were ambulatory at discharge (Frankel Grade D and E) compared to 20 patients (20%) prior to surgery.Fig. 2**a** Number of patients with either improved, stable or worsened Frankle Grade at discharge. **b** Differences between preoperative Frankel Grade and Frankel Grade on discharge (postoperative)

Functional improvement in the KPI score was observed in 75 patients (75%) and at discharge, 27% of patients had a KPI score ≥ 80 compared to 4% prior to surgery (Tables [2](#Tab2){ref-type="table"}, [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}).Table 4Univariate analysis of factors associated with regaining the ability to walk after surgery for 81 non-ambulatory patientsAmbulation regainedRelative risk (95% CI)p-valueyes (n = 41) (%)no (n = 40) (%)Demographic factors Age \> 70 years55451.171 \[0.693--2.000\]0.6528 Female sex38620.600 \[0.280--1.258\]0.2122 Primary tumor unknown71291.087 \[0.939--1.296\]0.264 Primary tumor  Prostate52481.041 \[0.600--1.1814\] \> 0.9999  Lung48520.887 \[0.428--1.830\]0.8036  Breast50500.976 \[0.283--3.364\] \> 0.9999 Progressive disease48520.884 \[0.673--1.143\]0.441Clinical presentation: First symptom  Pain58421.366 \[0.496--3.1812\]0.756  Sensory deficit56441.220 \[0.379--3.962\] \> 0.9999  Paresis46540.845 \[0.618--1.137\]0.3374  Bladder/bowl disorder75252.927 \[0.439--20.020\]0.6156 Duration of first symptom \> 7 d38621.25 \[0.919--1.744\]0.2324 Symptoms on admission  Back pain53470.818 \[0.518--1.305\]0.4736  Radiating pain67331.951 \[0.442--8.797\]0.6755  Sensory deficit53471.098 \[0.898--1.370\]0.3793  Paresis50501 \[0.914--1.096\] \> 0.9999  Bladder disorder54460.82 \[0.591--1.116\]0.238  Bowl disorder24760.3 \[0.134--0.640\]0.0015 Duration of paresis \> 7 days33671.22 \[0.963--1.597\]0.115 Paresis \< 4/5 BMRC grade47535.854 \[0.988--36.28\]0.1088 Non-ambulatory since \> 48 h62380.749 \[0.508--1.079\]0.1689 KPI \< 50%46544.39 \[1.162--17.4\]0.048 Frankel grade  A24760.300 \[0.109--0.788\]0.0148  B27730.366 \[0.110--1.172\]0.1157  C64341.746 \[1.257--2.567\]0.001 Frankel grade \< C25750.325 \[0.154--0.649\]0.001Imaging and clinical course Number of metastases  Solitary44560.767 \[0.397--1.463\]0.4769  2--562381.576 \[0.936--2.735\]0.1161  \> 541590.675 \[0.3261.373\]0.3256 Location of metastases  Cervical spine40600.65 \[0.135--3.109\]0.6755  Thoracic spine54461.128 \[0.934--1.403\]0.2258  Lumbar spine56441.22 \[0.379--3.962\]0.9999 ESCC scale (%)  247530.878 \[0.404--1.899\]0.7976  352481.041 \[0.808--1.351\]0.7976 Radiological signs of myelopathy48520.918 \[0.541--1.552\] \> 0.9999 SINS score  0--648520.918 \[0.728--1.143\]0.5609  7--1260401.463 \[0.596--3.66\]0.569 Tokuhashi score  0--845550.813 \[0.587--1.101\]0.2351  9--1162381.561 \[0.824--3.034\]0.2351 Emergency operation in \> 24 h55450.944 \[0.722--1.226\]0.7976  Operation in \> 48 h43571.03 \[0.881--1.122\]0.7123 ASA score \> 249511.665 \[0.645--4.415\]0.3822 Duration of surgery \> 120 min51491.025 \[0.660--1.598\] \> 0.9999 Complications occured50500.585 \[0.162--2.08\] \> 0.9999 Revision surgery necessary75252.927 \[0.439--20.02\]0.6156 Hospital stay \> 7 days40600.650 \[0.297--1.386\]0.3116The Fisher's exact test was used for univariate analysis*BMRC* British Medical Research Council, *KPI* Karnofsky performance index, *ASA* American Society of Anesthesiologists, *CI* confidence interval

Comparison of preoperative ambulatory and non-ambulatory patients {#Sec12}
-----------------------------------------------------------------

Statistical analysis of 81 ambulatory (Frankel Grade D--E) and 20 non-ambulatory (Frankel Grade A--C) patients prior to surgery revealed significant differences in perioperative variables (Table [3](#Tab3){ref-type="table"}): Non-ambulatory patients more frequently had paresis as their first symptom (p \< 0.05), whereas preoperative ambulatory patients more commonly were suffering from pain (p \< 0.05). Furthermore, the median KPI was lower for non-ambulatory patients compared to ambulatory patients (p \< 0.01). At admission, radiating pain was more common in ambulatory patients (p \< 0.01) whereas non-ambulatory patients experienced bladder and bowl dysfunction more frequently (both p \< 0.01). While all patients suffered from motor palsy when admitted to our institution, its' duration was shorter but its' degree higher (p \< 0.01 and p \< 0.001 respectively) in non-ambulatory patients. Non-ambulatory patients more often showed spinal cord compression with no visible CSF (ESCC scale = 3) in imaging studies (p \< 0.05) and had a predicted survival period of less than 6 months (p \< 0.05) according to the modified Tokuhashi score (0--8). In return, ambulatory patients more frequently had a predicted survival period of 1 year or more (Tokuhashi score 12--15; p \< 0.01). While the time to surgery was shorter in non-ambulatory patients, no significant difference could be noted (p = 0.06). Nevertheless, more non-ambulatory patients received surgical treatment within 48 h after admission (p \< 0.05). No further variables were found to be significantly different between both groups (Table [2](#Tab2){ref-type="table"}).

Identification of factors affecting postoperative ambulation {#Sec13}
------------------------------------------------------------

In univariate analyses, male sex, a better neurological status prior to surgery (for Frankel Grade and KPI), the absence of bladder or bowl dysfunction as well as a lower degree of motor palsy and a lower Tokuhashi score were associated with an ambulatory status at the time of discharge. No other factors were significantly correlated with the ability to walk after surgery (Table [3](#Tab3){ref-type="table"}).

Identification of predictors for regaining the ability to walk at discharge {#Sec14}
---------------------------------------------------------------------------

Statistical analyses of a subgroup of 81 patients who had lost the ability to walk prior to surgery showed significant negative associations with regaining ambulation at discharge for the following variables: Presence of bowl dysfunction at admission (RR 0.3; 95% CI 0.134--0.640; p = 0.0015), KPI \< 50% prior to surgery (RR 4.39; 95% CI 1.162--17.4; p = 0.048) and Frankel Grade \< C prior to surgery (RR 0.325; 95% CI 0.154--0.649; p = 0.001). Of note, patients who regained ambulation at discharge had presented with a median duration of their first symptom of 4 days (IQR 2.5--10.5 days) compared to 6.5 days (IQR 2--14) in patients who remained non-ambulatory and a median duration of muscle weakness of 3 days (IQR 2--7 days) compared to 4 days (IQR 1--13.5 days). These differences, however, did not reach statistical significance. No further clinical, imaging, surgical or pathological parameter was significantly affecting the recovery of ambulation at discharge (Table [4](#Tab4){ref-type="table"}).

Discussion {#Sec15}
==========

In this study of 101 neurologically impaired MSCC-patients without spinal instability that received decompressive laminectomy, 74% showed improved motor function and 51% had regained the ability to walk at discharge while overall complication rate as well as revision and mortality rates (6%, 4%, and 1%, respectively) were low. In univariate analyses, absence of bowl dysfunction, better neurological status as well as smaller surgery in terms of decompressed spinal levels were associated with postoperative retrieval of the ability to walk.

It is noteworthy that in contrast to many other published series \[[@CR53], [@CR54]\], all MSCC patients in our study had impaired motor function and 80% were unable to walk prior to surgery. To our knowledge, our study is the only clinical series that solely focusses on the surgical treatment of neurologically impaired MSCC patients. Additionally, our study population was older (66.1 ± 11.52 years mean ± SD) and had a more extensive metastatic disease (74% with extraspinal metastasis) than many of the MSCC patient cohorts in the literature \[[@CR55]\]. Furthermore, all MSCC patients that were treated by decompressive laminectomy in our study had a SINS score between 0 and 12, and therefore no relevant spinal instability. It needs to be emphasized that MSCC patients who underwent other surgical procedures (e.g. posterolateral fusion), which are mostly required when spinal instability is present, were excluded in our current study. Our findings hence should only be applied to MSCC patients with neurological impairment, a SINS score ≤ 12 and an extensive metastatic disease with limited life expectancy.

Differences in characteristics of preoperative ambulatory and non-ambulatory patients {#Sec16}
-------------------------------------------------------------------------------------

Loss of ambulation due to MSCC is mainly caused by motor palsy and spinal ataxia. Back pain or radiating pain may limit the patients´ mobility to some extent as well, but the objective Frankel Grade we used to assess the ambulatory status of MSCC patients does not inquire these symptoms. Our findings reflect the often-rapid progression of MSCC into MESCC which makes affected patients an oncological emergency \[[@CR13], [@CR16]\]. As expected, the KPI was lower in non-ambulatory patients, since it is influenced by the patients' ability to walk.

Further imaging analyses revealed a trend towards thoracic localization of spinal metastases in non-ambulatory patients with a higher rate of radiological signs of myelopathy which might be affected by the anatomical narrowing of the spinal canal in this region. Pretreatment evaluation of prognosis by the modified Tokuhashi score predicted a shorter survival period for non-ambulatory patients. However, it must not be forgotten that this score itself already includes KPI and Frankel Grade as two of its six prognostic factors. In addition, due to recent improvements in specific cancer therapies, and hence increased survival time of some MSCC patients, the modified Tokuhashi score, in which the primary tumor constitutes a major factor in estimating life expectancy, is thought to be increasingly limited \[[@CR39], [@CR56]\].

Non-ambulatory MSCC patients have been described to require more extensive surgery in terms of decompressed vertebral levels and to incur more complications \[[@CR18]\]. Due to possible difficulties in decompressing the spine in these cases, it has been recommended to perform early surgical interventions before MSCC patients become non-ambulatory \[[@CR34], [@CR35], [@CR57], [@CR58]\]. In our study, there were no statistically significant differences in the extent or duration of surgery as well as the length of hospital stay between preoperative ambulatory and non-ambulatory patients. However, complications and revision surgeries only occurred in non-ambulatory patients which might be influenced by their worse overall health status, assessed by preoperative ASA scores. Likewise, time to surgery was shorter for non-ambulatory patients. In contrast to other studies, these findings did not reach statistical significance in our analysis. The indication to perform early surgery on ambulatory MSCC patients without neurological impairment in order to prevent surgical complications should therefore be critically discussed \[[@CR18]\].

Decompressive laminectomy to maintain or regain ambulatory ability {#Sec17}
------------------------------------------------------------------

In their recent multicenter randomized study, Patchell et al. compared radiotherapy alone with both surgery and radiotherapy and revealed that aggressive surgical decompression and instrumented stabilization had half the mortality rate compared to radiotherapy alone. Additionally, patients in the surgical arm retained the ability to walk for significantly longer than those in the radiotherapy arm without spending increased time in the hospital \[[@CR59]\]. Although the study has been critically discussed due to a possible selection bias towards better outcome in the surgical arm as well as poor functional results after radiotherapy alone when compared with the literature \[[@CR60]\], it confirmed the importance of surgery in the treatment of MSCC patients.

Today, extensive surgical techniques to treat MSCC patients with e.g. circumferential instrumentation and fusion or corporectomy and cage graft placement from an anterolateral, posterolateral or retroperitoneal approach are available \[[@CR61]\]. It has to be noted that goals of surgery with such approaches usually go beyond restoration or preservation of neurological function and include deformity correction and stabilization as well as oncologic control \[[@CR62]\].

However, rates of complications for the surgical treatment of MSCC patients reported in the literature with more extensive approaches are high and range between 10 and 48% \[[@CR54], [@CR55], [@CR63]--[@CR68]\]. Our current data reinforces this problem: MSCC patients were of higher age, had progressive disease in most of cases, a reduced functional status (KPI) prior to surgery and severe systemic symptoms (ASA 3 or 4). These are some of the typically increased risk factors for such local and systemic complications after surgery \[[@CR55]\]. Laminectomy, a surgical technique that allows fast decompression of the spinal cord in cases of MSCC with the possibility of obtaining a histological sample or further tumor debulking has been pushed into an increasingly marginal role in the last decades \[[@CR69]\]. Although surgical complication rates are generally low, the technique has fallen into disrepute for causing vertebral collapse and possible neurologic deterioration which in return may have resulted in the increased use of radiotherapy for MSCC treatment in the past \[[@CR7]\]. Nevertheless, our data suggests that decompressive laminectomy might provide significant outcome benefits for a specific cohort of MSCC patients. In our study, all patients had a SINS score \< 13, and therefore no evidence for spinal instability. Because the SINS score was specifically developed to assess the stability of the spine in MSCC patients, it has been proven to be reliable and reproducible with a sensitivity and specificity for potentially unstable lesions of 95.7% and 79.5% respectively \[[@CR49]\]. In addition, 98% of the patients in our series had an ESCC scale of 2 or 3 and therefore profound spinal cord compression, 100% suffered from motor weakness at admission and 80% were unable to walk prior to surgery since only 24--96 h.

Compared to other surgical series in the literature, the postoperative impact of decompressive laminectomy on the ambulatory status of our MSCC patients was high: Chong et al. reported an improved Frankel Grade in 20% of 105 MSCC patients after single-stage posterior decompression and stabilization with a complication rate of 10% and a revision rate of 10% \[[@CR64]\]. Fourney et al. published a series of 72 MSCC patients treated by transthoracic vertebrectomy which lead to functional improvement in 59% of cases with a complication rate of 35% and 3% mortality \[[@CR35]\]. Jansson et al. assessed 282 MSCC patients who underwent different surgical approaches, reporting functional improvement in 70% of cases with a complication rate of 20% and 13% mortality in the first months after surgery \[[@CR55]\]. In our study, no MSCC patient lost the ability to walk after surgery, 74% had functional improvement at discharge and 51% had regained the ability to walk while overall complication rate as well as revision and mortality rates (4%, 2% and 1% respectively) were low. Even completely paraplegic patients became walkers at discharge after emergency decompressive laminectomy in 25% of cases.

Like other authors, we found that a better neurological status (KPI \> 40%, FG \> C) prior to surgery is associated with the ability to walk at discharge \[[@CR34], [@CR35], [@CR70], [@CR71]\]. Moreover, our data suggests that higher KPI (\> 40%) and better FG (\> C) at admission are predictors even for non-ambulatory patients to regain the ability to walk after surgery. Surprisingly, duration of motor weakness or duration of the inability to walk prior to surgery had no significant impact on the ambulatory status at discharge, although trends towards shorter durations could be observed. Likewise, an earlier timepoint of surgery after admission of MSCC patients (\</\> 24 h) showed no association with postoperative ambulation. We assume, that these findings might be related to the small sample size in our study. Nevertheless, in order to alleviate damage to the spinal cord and thus allow for better recovery of neurological function, prompt surgical intervention should be performed in MSCC patients before edema, venous congestion and secondary vascular injury due to compression occur \[[@CR18], [@CR59]\].

In our analyses, a lower modified Tokuhashi score (0--8) as well as the presence of bladder- and bowl dysfunction at admission were associated with the inability to walk at discharge. Moreover, the presence of bowl dysfunction was a predictor for non-ambulatory patients to remain unable to walk after surgery. Although the Tokuhashi score itself is partly determined by the patients' ambulatory status, we deem it a useful tool to predict not only prognosis for survival but also for postoperative ambulation. Interestingly, Tokuhashi et al. already recommend conservative treatment for MSCC patients with a total score of 8 or less due to a predicted survival period of \< 6 months \[[@CR39]\]. To this recommendation, our data adds the finding that these patients may also have a worse functional outcome when treated surgically. The presence of bowl dysfunction at admission might be an additional prognostic factor to predict the postoperative functional outcome of MSCC patients.

Limitations {#Sec18}
-----------

Our study is primarily limited by its retrospective design and the corresponding lack of a prospective follow up assessing the long-term neurological status, development of spinal instability and the survival of MSCC patients. Moreover, we are unable to present data on further adjuvant treatments. Although we demonstrate objective and immediate effects of decompressive laminectomy on the ambulatory status, the alteration of ambulation over time which is expected to decrease depending on e.g. local radiation or local tumor recurrence therefore remains unknown. Similarly, possible secondary instability in e.g. patients with laminectomy over the cervico-thoracic or thoraco-lumbar junction cannot be addressed. However, information on direct effects of the surgical treatment on the functional status are equally important for affected patients and treating physicians. Secondly, due to its single center design and its relatively long time period, our study is prone to selection bias and heterogeneity in treatment due to secular changes. Nevertheless, decompressive laminectomy as a surgical technique did not change during the 10-year period of our analysis and there was no significant difference in surgery time or rate of complications between patients who were operated within the first 5 vs. the last 5 years of the study. Thirdly, the onset of motor symptoms, usually reported by the patients themselves, is only loosely defined in our series, which limits our results regarding neurologic improvement and outcome after surgery. Prospective studies are certainly needed to provide better data on the long-term effect of decompressive laminectomy and to guide clinical decision-making in the surgical treatment of MSCC patients.

Conclusion {#Sec19}
==========

Our data demonstrates a beneficial effect of decompressive laminectomy on the ambulatory status at discharge in the treatment of 101 neurologically impaired MSCC patients: 61 (61%) patients could walk at discharge compared to only 20 (20%) who were able to ambulate preoperatively. More importantly, patients with preserved sensation only or even complete loss of any motor or sensory function (FG A + B) regained ambulation in 25% of cases. Additionally, surgical (4%) and general complications (2%) as well as mortality (1%) after decompressive laminectomy were low. In univariate analysis, the absence of bowl dysfunction as well as a better neurological status prior to surgery were associated with postoperative retrieval of the ability to walk.
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